LECANEMAB RECEIVES PRIORITY REVIEW STATUS IN JAPAN ...Middle East

PR Newswire - News
LECANEMAB RECEIVES PRIORITY REVIEW STATUS IN JAPAN
TOKYO and CAMBRIDGE, Mass., January 29, 2023 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced today that an application for...

Read More Details
Finally We wish PressBee provided you with enough information of ( LECANEMAB RECEIVES PRIORITY REVIEW STATUS IN JAPAN )

Apple Storegoogle play

Also on site :



Latest News